相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Towards accurate detection and genotyping of expressed variants from whole transcriptome sequencing data
Jorge Duitama et al.
BMC GENOMICS (2012)
Exploiting the Mutanome for Tumor Vaccination
John C. Castle et al.
CANCER RESEARCH (2012)
Minimal Tolerance to a Tumor Antigen Encoded by a Cancer-Germline Gene
Ivo J. Huijbers et al.
JOURNAL OF IMMUNOLOGY (2012)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
Confidence-based Somatic Mutation Evaluation and Prioritization
Martin Loewer et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Tumor vaccination using messenger RNA: prospects of a future therapy
Sebastian Kreiter et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma
Stephen J. Schuster et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Tumour evolution inferred by single-cell sequencing
Nicholas Navin et al.
NATURE (2011)
Mutational Heterogeneity in Human Cancers: Origin and Consequences
Jesse J. Salk et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Accumulation of driver and passenger mutations during tumor progression
Ivana Bozic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy With Mitumprotimut-T and Granulocyte-Macrophage Colony-Stimulating Factor After Rituximab in Patients With Follicular Lymphoma
Arnold Freedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Modeling the Repertoire of True Tumor-Specific MHC I Epitopes in a Human Tumor
Nisheeth Srivastava et al.
PLOS ONE (2009)
Epitope landscape in breast and colorectal cancer
Neil H. Segal et al.
CANCER RESEARCH (2008)
IFN-γ- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers
Bin Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
An adjuvant autologous therapeutic vaccine (HSPPC-96 vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentrel, open-label, randomised phase III trial
Christopher Wood et al.
LANCET (2008)
It is the antigen(s), stupid and other lessons from over a decade of vaccitherapy of human cancer
Matthew R. Buckwalter et al.
SEMINARS IN IMMUNOLOGY (2008)
Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen
PR Hess et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
The response of autologous T cells to a human melanoma is dominated by mutated neoantigens
V Lennerz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Therapeutic vaccines for melanoma - Current status
MB Faries et al.
BIODRUGS (2005)
Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation
Y Delneste et al.
IMMUNITY (2002)
The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein
T Matsutake et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
CD91: a receptor for heat shock protein gp96
RJ Binder et al.
NATURE IMMUNOLOGY (2000)
分享论文
